RankAlpha logo
Back to Rankings

SENS

SenseonicsF
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
The best post-earnings bull argument is that Q1 showed real commercialization traction: revenue nearly doubled year over year, U.S. revenue more than doubled, gross margin expanded to 59%, and FY2026 revenue guidance was raised [#8-K-2026-05-07].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +3.4.
What can break
Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
Momentum
100
Value
37
Sentiment
20
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $7.20 · Bear $4.10Analysis 2026-05-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $13.40
Why
Momentum100 · Δ7d -0.1
Value37 · Δ7d -0.0
Sentiment20 · Δ7d +3.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta +3.4.

Contradictions & invalidation

  • Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
  • Europe launch, reimbursement, tender timing, and additional AID compatibility are all execution-sensitive in medtech and could slip or scale slower than hoped.
  • The bear case is that the good topline still sits inside a cash-burning transition story: SG&A surged to $30.2M as Senseonics absorbed commercialization from Ascensia, net loss widened to $32.3M, and the stock now has to prove that DTC spending, Europe handoff, and AID partnerships can translate into durable demand rather than one strong quarter [#10-Q-2026-05-07].

Catalyst clock

2026-05-20

Q1 print lifted FY2026 revenue outlook but post-print setup still needs confirmation

Lead driver: Sentiment · See AI snapshot
Momentum
100
9% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+1.9
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
20
62% active weight
Current posture
7d trendImproving
Δ7d
+3.4
Δ21d
-3.4
Why this grade

Composite grade F. Momentum 99.6 / Value 36.6 / Sentiment 19.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-09. Scenario method

B+
Bull case
0%
Probability
Target price
$7.20
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
Most likely
B
Base case
1%
Probability
Target price
$5.60
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$4.10
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$424.58M
Beta
0.99
Shares Out
52.87M
P/E (TTM) · Derived
-4.8
P/S (TTM)
8.47
P/FCF (TTM) · Derived
-3.94
Rev YoY
+117.8%
EPS YoY
+78.0%
Gross Margin
+54.9%
Op Margin
-223.2%
Net Debt
-$52.97M
Current Ratio
6.74
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data